Development of methods for measurement of diagnostic markers in patient samples by mass spectrometry
Evaluation of Clinical Reference Laboratories
Participation in comparative studies with other National Metrology Institutes (as NIST, NPL, LGC, LNE, NMIA) to maintain international equivalence and reliability of measurements at highest level of precision
Development of novel mass-spectrometry based measurement methods for protein markers to backup quality management in clinical routine laboratories
Basic research to early discovery of upcoming measurement challenges in the biomedical area and development of appropriate (bio-) metrological responses
Foto: PTB
Research
Analytical Biochemistry: Protein analysis by mass spectrometry
Quantitative Proteomics: Protein quantification in complex samples (as serum) using isotope dilution mass spectrometry (IDMS)
Isoform-specific quantification of growth hormone (somatotropin) in serum by IDMS
Characterization of 3D-protein structure by chemical cross-linking/ mass spectrometry
Mass spectrometric investigations about peptide-membrane complexes and peptide self assembly
Projects
Metrology for biomolecular origin of disease (BiOrigin, EMRP-Call 2011, HLT10) 01.06.2012-31.05.2015 (co-ordinated by PTB)
Metrology for metalloproteins (Metallomics, EMRP-Call 2011, HLT05) 01.05.2012-30.04.2015
Traceability of complex biomolecules and biomarkers in diagnostics- effecting measurement comparability in clinical medicine (ClinBioTrace, iMERA-Plus 2008, T2.J.11) 01.06.2008-31.05.2011
Feasibility to develop reference measurement systems for Thyrotropin (TSH) and for free Thyroxine (FT4), and validation of reference measurement systems (procedure and material) for Thyroxine (T4) and Triiodothyronine (T3) in human serum (IVD-NONSI-THYROID, EU FP5-Growth) 01.11.2001-31.12.2005
Publications
André Henrion
Cristian Arsene
Anita Röthke
Michael Rettig
Contact
Head of Working Group
Dr.rer.nat. André Henrion Tel.: +49 (0)531-592-3120 Email: André Henrion